(Q47788877)

English

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.

scientific article published on 22 June 2017

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Richard A Hubner

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Tim Meyer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Richard Fox

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Paul J Ross

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Martin W James

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Richard Sturgess

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Clive Stubbs

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Deborah D Stocken

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Lucy Wall

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Anthony Watkinson

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Nigel Hacking

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

T R Jeffry Evans

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Peter Collins

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Philip J Johnson

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Daniel H Palmer

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

David Cunningham

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

23 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

The lancet. Gastroenterology & hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

565-575

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A general inefficacy interim monitoring rule for randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous analysis of quality of life and survival data.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930156-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(17)30156-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28648803%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47788877&oldid=1501168711"